US FDA Medical Device Regulatory Submissions

FDA regulatory submission support for medical devices including 510(k), De Novo, and PMA strategy.

US FDA Medical Device Regulatory Submissions_page-0001

US FDA Regulatory Submission Services

Bioexcel provides FDA regulatory support for medical devices, assisting manufacturers in preparing compliant submissions and responding to FDA queries efficiently.

Replace current paragraph with:

Bioexcel supports manufacturers in designing and executing FDA regulatory pathways across 510(k), De Novo, PMA, and IDE submissions.
Our approach integrates regulatory intelligence, clinical evidence strategy, and structured submission architecture to minimize deficiencies and accelerate FDA review cycles.

SEND YOUR ENQUIRY

Submission Development & Execution

510(k) preparation (Traditional / Special / Abbreviated)
De Novo classification requests
PMA submission strategy & module preparation
Clinical evidence mapping & gap assessment
Human factors & usability documentation
Risk management alignment (ISO 14971)
Software documentation (per FDA guidance)
FDA deficiency response management

CAPABILITIES & REGULATORY (Upgrade This Section)

FDA Regulatory Capabilities

Strategic Pathway Determination

Device classification & product code analysis

Predicate device identification & substantial equivalence strategy

Regulatory pathway determination (510(k), De Novo, PMA, HDE)

Pre-Submission (Q-Sub) & FDA interaction strategy

IDE strategy for significant risk devices

DIFFERENTIATION BLOCK (Add This — Important)

Beyond Submission Preparation

We structure FDA submissions with:

Clear claim-to-evidence traceability

Deficiency mitigation planning

Structured clinical justification

Risk-based argumentation

Pre-emptive reviewer concern identification

Our objective: reduce review cycles, avoid major deficiency letters, and strengthen clearance probability.

Capabilities & Regulatory

Capabilities –Regulatory pathway & classification – 510(k), De Novo, PMA support – Clinical evidence mapping – FDA deficiency response support

Regulatory – 21 CFR, FDA guidance documents

US FDA Regulatory Strategy & Submissions

Structured Pathways to 510(k), De Novo & PMA Approval
Regulatory strategy, submission preparation, and FDA-facing execution for medical devices and IVDs.
From classification to clearance — engineered for compliance, defensibility, and review efficiency.

Discuss Your EU MDR / IVDR Strategy

US FDA Medical Device Regulatory Submissions_page-0002

Regulatory Framework Alignment

Our submissions align with:

21 CFR Part 807 (510(k))
21 CFR Part 814 (PMA)
21 CFR Part 812 (IDE)
21 CFR Part 820 (QMSR transition readiness)
FDA Guidance Documents & Review Memoranda
Human Factors Engineering Guidance
Cybersecurity & Software Guidance

We design submissions anticipating FDA review expectations-not reacting to them.

Frequently Asked Questions (FAQ)

Does Bioexcel guarantee regulatory approval?Bioexcelife2026-02-10T09:22:59+00:00

Does Bioexcel guarantee regulatory approval?

No. Bioexcel supports compliant preparation and strategy; final approval decisions rest with regulatory
authorities.

Can the same clinical evidence be used across regions?Bioexcelife2026-02-10T09:24:10+00:00

Can the same clinical evidence be used across regions?

Often yes, with region-specific adaptations based on regulatory requirements.